BRCA2 and colorectal cancer: The indication for performing a conventional “blind” prostate biopsy four years ago in a 57-year-old patient was the presence of lower urinary tract symptoms (LUTS) accompanied by persistently elevated PSA levels and a family history of colorectal cancer, along with reported BRCA2 mutation carrier status (as stated by the patient; no confirming medical documentation was available).